Delivery Order SPE2DR25D3020-SPE2DR26F9P6B
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,874.06 on November 18, 2025, for the supply of Ingrezza 40 mg capsules (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 10, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,244.58 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) on November 12, 2025, with a completion date of December 4, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules in a 30-count package, valued at $8,055.38. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of November 18, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's primary location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) on September 18, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count) valued at $12,083.10 under a firm fixed-price contract type. The award was issued on September 18, 2025, with an ultimate completion date of October 9, 2025, and represents a non-competitive delivery order under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Ingrezza 80 mg capsules (30-count) with a ceiling value of $4,027.69. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.69 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) on November 5, 2025, with an ultimate completion date of November 28, 2025. This firm fixed-price, non-set-aside contract represents a competitive award for pharmaceutical products supporting federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,622.18 to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count units). This firm fixed-price delivery order, awarded on November 7, 2025, with an ultimate completion date of December 2, 2025, represents a non-set-aside competitive procurement. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,874.06 to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count units). This competitively awarded, firm fixed-price contract was issued on November 4, 2025, with an ultimate completion date of November 26, 2025. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DR25D3020Indefinite Delivery Contract
- SPE2DR25D3020-SPE2DR26F9P6BDelivery Order
The Defense Logistics Agency (DLA) awarded a $4,244.58 delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price contract. This non-competitive award, issued on December 3, 2025, with completion scheduled for December 24, 2025, represents a child order under AmerisourceBergen's larger prime indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's Conshohocken, Pennsylvania location, which serves as the prime vendor hub for federal medical procurement. This delivery order is executed under AmerisourceBergen's comprehensive $999.99 billion Pharmaceutical Prime Vendor Global Program IDC (SPE2DX) with DLA Troop Support Medical, which extends through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medications across multiple therapeutic domains to support Department of Defense healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The Ingrezza order supports neurological treatment needs within military healthcare programs, consistent with the company's extensive portfolio of specialty medications delivered through competitively awarded federal contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 12/2/25 |